To explore the impact of ECI2 on ccRCC tumor cells, we developed a cell line overexpressing ECI2. The findings indicate that overexpression of ECI2 suppresses tumor cell growth and migration and enhances ccRCC cells' sensitivity to oxaliplatin. The gene discussed is ECI2; the disease is neoplasm.